News from invitae corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 08, 2023, 16:01 ET Invitae Reports Third Quarter 2023 Financial Results

...

Nov 06, 2023, 16:00 ET Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research Partnerships

Invitae (NYSE: NVTA), a leading medical genetics company, today announced enhanced chemistry of its Invitae Personalized Cancer Monitoring™ platform...

Nov 01, 2023, 06:59 ET Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023

Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it will report its third quarter 2023 financial results on Wednesday,...

Oct 25, 2023, 11:00 ET Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive Results

Invitae (NYSE: NVTA), a leading medical genetics company, today announced findings from the largest study to date on uncertain results from...

Oct 19, 2023, 16:30 ET Invitae Appoints Dr. David Sholehvar as Chief Operating Officer

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of veteran healthcare leader David Sholehvar, M.D., as...

Oct 12, 2023, 16:15 ET Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast Cancer

Invitae (NYSE: NVTA), a leading medical genetics company, today announced results of its collaborative study on universal hereditary cancer genetic...

Oct 10, 2023, 16:30 ET Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical Genomics

Researchers from Invitae (NYSE: NVTA), a leading medical genetics company, are showcasing their work next week at the National Society of Genetic...

Oct 03, 2023, 12:07 ET Invitae's Common Hereditary Cancers Panel Receives FDA Market Authorization

Invitae (NYSE: NVTA), a leading medical genetics company, today announced it gained FDA market authorization for its Common Hereditary Cancers Panel. ...

Sep 25, 2023, 16:30 ET Invitae Announces Appointment of Finance Veteran Ana Schrank as CFO

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of finance veteran Ana Schrank as the Company's chief...

Sep 22, 2023, 16:30 ET Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing Standard

Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it received a notice from the New York Stock Exchange (the "NYSE") on...

Aug 28, 2023, 16:02 ET Invitae Hires Industry Veteran Robert Guigley as Chief Commercial Officer

Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it has appointed Robert (Rob) Guigley as its chief commercial officer, ...

Aug 15, 2023, 07:30 ET Clinical Trial Results Support Genetic Testing of All Patients with Prostate Cancer

Invitae (NYSE: NVTA), a leading medical genetics company, today announced findings from its PROCLAIM trial, published in European Urology Oncology,...

Aug 14, 2023, 16:02 ET Invitae Announces Selection of Finance Executive Robert Dickey as Interim CFO

Invitae (NYSE: NVTA), a leading medical genetics company, today announced that Robert Dickey has been named its interim chief financial officer...

Aug 08, 2023, 16:01 ET Invitae Reports Second Quarter 2023 Financial Results

– Reported revenue of $120.5 million, a 12% year-over-year decrease due to exited businesses and geographies; pro forma revenue up slightly...

Jul 26, 2023, 16:01 ET Invitae to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it will report its second quarter 2023 financial results on Tuesday,...

May 31, 2023, 06:59 ET Invitae to Present at the William Blair 43rd Annual Growth Stock Conference

Invitae (NYSE: NVTA), a leading medical genetics company, today announced that Ken Knight, president and chief executive officer, will present at the ...

May 26, 2023, 08:01 ET New Research Insights to be Presented by Invitae at the 2023 ASCO Annual Meeting Reinforce the Critical Role of Germline Genetic Testing in Oncology

Invitae (NYSE: NVTA), a leading medical genetics company, today announced nine studies to be presented at the 2023 American Society of Clinical...

May 25, 2023, 19:00 ET Invitae Announces CFO Transition and Selection of Veteran Finance Executive Christine Gorjanc as Interim CFO

Invitae (NYSE: NVTA), a leading medical genetics company, today announced that Chief Financial Officer (CFO) Yafei (Roxi) Wen is resigning to pursue...

May 15, 2023, 16:07 ET Invitae to Appeal Trial Verdict

Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it intends to appeal the verdict delivered by a jury at the United...

May 09, 2023, 16:01 ET Invitae Reports First Quarter 2023 Financial Results

...

Apr 26, 2023, 06:59 ET Invitae to Announce First Quarter 2023 Financial Results on Tuesday, May 9, 2023

Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it will report its first quarter 2023 financial results on Tuesday,...

Apr 17, 2023, 16:30 ET Invitae Publishes Annual Environmental, Social and Governance (ESG) Report

Invitae (NYSE: NVTA), a leading medical genetics company, today published its 2023 Environmental, Social and Governance (ESG) Report. This report...

Apr 13, 2023, 08:45 ET New Study Findings Published in Nature Show Circulating Tumor DNA (ctDNA) Can Predict and Detect Cancer Recurrence Earlier In Non-Small Cell Lung Cancer

Invitae (NYSE: NVTA), a leading medical genetics company, today announced new research published in Nature describing the first use of the company's...

Mar 22, 2023, 07:30 ET Invitae and Deerfield Management Partner to Create Novel Therapeutics for Rare Diseases

Invitae (NYSE: NVTA), a leading medical genetics company, and Deerfield Management Company, a healthcare investment firm, today announced a...

Mar 21, 2023, 07:30 ET Invitae Announces Partnership with Epic to Streamline Genetic Testing

Invitae (NYSE: NVTA), a leading medical genetics company, today announced its partnership with Epic, an industry-leading healthcare software company. ...